只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-16 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 124,893 | US$8.89 | US$111.03万 | 16,763,043 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-15 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 15,414 | US$8.99 | US$138,571.86 | 16,638,150 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-12 2026-06-16 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 391,019 | US$8.57 | US$335.1万 | 16,622,736 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-11 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 548,580 | US$7.91 | US$433.93万 | 16,231,717 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-10 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 103 | US$7.00 | US$721.00 | 15,683,137 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-06-09 2026-06-11 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 479,039 | US$6.91 | US$331.02万 | 15,683,034 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Aslan Fred Director,Officer · Chief Executive Officer | 卖出（S） | 27,116 | US$9.01 | US$244,315.16 | 1,535,082 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Banerjee Subhashis Officer · Chief Medical Officer | 卖出（S） | 7,037 | US$9.01 | US$63,403.37 | 144,963 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Bush Jennifer Officer · COO, CLO, Compliance Officer | 卖出（S） | 8,790 | US$9.01 | US$79,197.90 | 337,920 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Horan Christopher Officer · Chief Tech Operations Officer | 卖出（S） | 7,002 | US$9.01 | US$63,088.02 | 293,450 | SEC |
| 2026-05-19 2026-05-19 | ARTV Artiva Biotherapeutics, Inc. | Raymon Heather Officer · SVP, Research and Development | 卖出（S） | 3,095 | US$9.01 | US$27,885.95 | 148,228 | SEC |
| 2026-05-11 2026-05-28 | ARTV Artiva Biotherapeutics, Inc. | GC Corp. TenPercentOwner | 买入（P） | 1,085,069 | US$11.52 | US$1250万 | 4,391,969 | SEC |
| 2026-05-11 2026-05-28 | ARTV Artiva Biotherapeutics, Inc. | GC Cell Corp TenPercentOwner | 买入（P） | 1,085,069 | US$11.52 | US$1250万 | 4,391,969 | SEC |
| 2026-05-11 2026-05-28 | ARTV Artiva Biotherapeutics, Inc. | GC Corp. TenPercentOwner | 买入（P） | 347,222 | US$11.52 | US$400万 | 1,607,734 | SEC |
| 2026-05-11 2026-05-28 | ARTV Artiva Biotherapeutics, Inc. | GC Cell Corp TenPercentOwner | 买入（P） | 347,222 | US$11.52 | US$400万 | 1,607,734 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 2026-05-11 2026-05-13 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 6,510,416 | US$11.52 | US$7500万 | 15,203,995 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ARTV | 117,221.8532 | 1,900 | 160,953.9362 | 72.83% | B, Q, N |